HIGHLIGHTS
- who: Edy Kornelius and colleagues from the Department of Internal Medicine, Division of Endocrinology and Metabolism, Chung Shan Medical University Hospital, Taichung, Taiwan have published the Article: Liraglutide Attenuates Glucolipotoxicity-Induced RSC96 Schwann Cellsu2019 Inflammation and Dysfunction, in the Journal: Biomolecules 2022, 1338 of /2022/
- what: The authors investigated how GLP-1 RA protects against RSC96 SCs dysfunction through a diabetic condition mimicked by high glucose and high free fatty acid (FFA). Although the detailed role of insulin signaling in SCs is still unclear, the study confirmed that impaired insulin signaling in SCs may be . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.